Chemed
299 hedge funds and large institutions have $3.72B invested in Chemed in 2017 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 74 increasing their positions, 107 reducing their positions, and 20 closing their positions.
220% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 20
58% more call options, than puts
Call options by funds: $9.11M | Put options by funds: $5.78M
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
17% more capital invested
Capital invested by funds: $3.18B → $3.72B (+$542M)
15% more funds holding
Funds holding: 259 → 299 (+40)
2.5% less ownership
Funds ownership: 98.47% → 95.97% (-2.5%)
31% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 107
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$18.7M |
| 2 |
BlackRock
New York
|
+$11.2M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.69M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$8.23M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$24.5M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$14.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$12.8M |
| 4 |
Neuberger Berman Group
New York
|
-$12.3M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$12.2M |
CHE Hedge Fund Activity: Q4 2017 in Review
299 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2017, worth a combined $3.72B — up 17% from $3.18B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new CHE positions and 20 closed out — a net gain of 44 holders — while 74 added to existing stakes and 107 trimmed.
The largest buyer was Eaton Vance Management, opening a new position worth an estimated $18.7M. The largest seller was JP Morgan Chase, cutting an estimated $24.5M.
- 299 institutional investors held Chemed (CHE) as of Q4 2017, up from 259 in Q3 2017.
- Funds reported $3.72B of Chemed stock for Q4 2017, up 17% quarter-over-quarter.
- 64 funds opened new Chemed positions in Q4 2017 and 20 closed out, a net change of +44 holders.
- The largest Chemed buyer in Q4 2017 was Eaton Vance Management, an estimated $18.7M added.
- The largest Chemed seller in Q4 2017 was JP Morgan Chase, an estimated $24.5M sold.
Based on aggregated 13F filings for Q4 2017.